In-Stock Prime Editing Cell Lines & Precision Editing Services | EDITGENE
Used by academic, biotech, and pharmaceutical research teams worldwide.
Prime Editing success depends not only on the editor itself, but on system design, delivery strategy, and downstream validation.
EDITGENE’s BINGO™ Prime Editing Platform is designed to support precision gene editing and Prime Editing services with reproducible performance across multiple cell types.
1. Systematic Design, Not Trial-and-Error
● Target-specific pegRNA strategy
● Editing window and sequence context evaluation
● Risk assessment for efficiency and byproduct formation
Reduces unnecessary iterations and shortens development timelines.
2. Proven Across Multiple Cell Types
● Common immortalized cell lines
● Cancer cell models
● Hard-to-edit backgrounds
Select feasible editing strategies early, improving project predictability.
Efficient editing system
Efficient pegRNA design algorithm system
Enhanced Cas9n-RT editing enzyme system
Efficient transfection system
Efficient single clone sorting technology
Technical support provided by experienced experts
For many research programs, timelines and feasibilities are the primary bottleneck.
Our in-stock Prime Editing (PE) cell lines are pre-engineered and QC-validated, enabling immediate experimental deployment for precision gene editing studies.
What this means for your team:
Reduced project lead time
Faster experimental validation
Predictable delivery and documentation
Seamless integration into downstream workflows
Check out our PE in-stock page here
Our in-stock PE cell lines are designed for projects that require speed, consistency, and clean genetic edits.
Key Features
● Prime Editing–based precise genomic modifications
● QC-verified genotypes
● Stable genetic backgrounds
● Ready for immediate shipmen
Functional Genomics
● Genotype–phenotype correlation studies
● Mechanistic analysis of gene function
Disease Modeling
● Oncology-relevant variant studies
● Rare disease research and mutation impact assessment
Drug Discovery & Target Validation
● Pathway interrogation under controlled genetic backgrounds
● Proof-of-concept studies for early discovery programs
Assay Development
● Cross-project and cross-site experimental consistency
● Stable genetic models for reproducible assays
Academic & Research Institutions
● Grant-driven projects
● Publication-focused studies
● Need for validated, reproducible genetic models
Biotech & Emerging Companies
● Time-sensitive discovery programs
● Early target validation and screening
● Resource-efficient experimental execution
Pharmaceutical & Translational Research Teams
● Standardized models across programs
● High requirements for QC and documentation
● Integration into established assay pipelines
For studies that require bespoke genetic modifications, our Prime Editing services provide precise, flexible solutions aligned with modern research demands.
Supported Use Cases
● Custom SNVs
● Small insertions or deletions
● Disease-relevant point mutations
● Clean edits without double-strand breaks
Each project undergoes technical feasibility assessment and is supported by documented QC deliverables.
During the current promotion period, we are offering:
● Preferential pricing on select in-stock PE cell lines
● Free technical evaluation for Prime Editing service inquiries
● Priority assessment for projects submitted during the campaign window
Offer valid for a limited time. Availability subject to stock and project scope.
What role does gene knock-in play in drug development?
Why choose EDITGENE, and what are EDITGENE’s main advantages in gene knock-in technology?
What is the core principle of gene knock-in technology?
In EDITGENE, we value
Follow Us
